TechTalk: ADC characterization in one native LC-MS workflow
Friday, September 4 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT
Achieving comprehensive antibody-drug conjugate (ADC) characterization no longer requires complex multi-step workflows. Advances in native LC-MS are creating new opportunities to simplify ADC analysis while maintaining the depth of information needed to support development decisions.
In this SelectScience® TechTalk, Roxana Eggleston-Rangel, Senior Applications Scientist at Phenomenex, will showcase how Biozen® Native RP-1 and RP-5 columns enable direct drug-to-antibody ratio (DAR) analysis through a streamlined, MS-compatible native reverse-phase liquid chromatography-mass spectrometry (RP-LC-MS) workflow.
Learn how this approach supports DAR determination, proteoform characterization, and positional isomer resolution without fraction collection or buffer exchange while maintaining native conditions.
Using case studies featuring the approved ADC therapies Enhertu®, Padcev®, Polivy®, and Adcetris®, Eggleston-Rangel will demonstrate how this workflow can be applied across a range of ADC modalities and payload chemistries. In just 20 minutes, discover how the same approach can support both high-resolution mass spectrometry and routine UV-based DAR monitoring, bringing greater efficiency and confidence to ADC characterization.
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on-demand recording once it becomes available.
Speakers
Who should attend?
- Pharmaceutical and biopharmaceutical characterization scientists
- Analytical development managers and directors overseeing LC-MS workflows
- Researchers developing methods for ADC characterization, drug-to-antibody ratio (DAR) analysis, and isomer identification
Featured products
Request Quote for All Products
Biozen Native RP-1
Phenomenex IncNative RP-1, developed in tandem with Native RP-5, is an advanced chromatography column designed to revolutionize ADC DAR analysis.
Biozen Native RP-5
Phenomenex IncDeveloped alongside Native RP-1, Native RP-5 is an advanced chromatography column designed to transform ADC DAR analysis.
What will this webinar cover?
- How native RP chromatography can be used for streamlined ADC DAR characterization and intact mass analysis.
- Best practices for selecting Biozen® Native RP columns based on ADC properties and analytical goals.
- How a single workflow can provide DAR determination, proteoform characterization, and positional isomer information.
- Real-world examples demonstrating how native RP-LC-MS can improve efficiency while reducing sample preparation complexity.
Join the TechTalk to get answers to these questions:
- How can native RP-LC-MS simplify comprehensive ADC characterization workflows?
- How do Biozen® Native RP-1 and RP-5 columns enable direct intact ADC analysis?
- How is drug-to-antibody ratio (DAR) accurately determined under native conditions?
- How can native RP-LC-MS resolve proteoforms and positional isomers in ADCs?
- What insights were gained from case studies on Enhertu®, Padcev®, Polivy®, and Adcetris®?